NXL
Nexalin Technology Inc.
NASDAQ: NXL · HEALTHCARE · MEDICAL DEVICES
$0.36
+2.42% today
Updated 2026-04-30
Market cap
$8.34M
P/E ratio
—
P/S ratio
27.63x
EPS (TTM)
$-0.50
Dividend yield
—
52W range
$0 – $2
Volume
0.6M
Nexalin Technology Inc. (NXL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-1,404.00%
ROE
-221.50%
ROA
-118.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $207383.00 | $-5.02M | -5.22% | -706.98% | -2,421.22% |
| 2020 | $242914.00 | $-3.40M | 88.05% | -1,341.38% | -1,401.11% |
| 2021 | $144065.00 | $-6.08M | 85.12% | -4,177.70% | -4,218.93% |
| 2022 | $1.32M | $-1.70M | 72.51% | -138.72% | -128.49% |
| 2023 | $110748.00 | $-4.65M | 76.80% | -5,143.48% | -4,197.56% |
| 2024 | $168721.00 | $-7.61M | 78.31% | -4,596.14% | -4,508.73% |
| 2025 | $301647.00 | $-8.22M | -543.35% | -2,781.69% | -2,725.76% |